<DOC>
	<DOC>NCT02456974</DOC>
	<brief_summary>Pharmacokinetics of antibiotics in critically ill neonates, infants and children</brief_summary>
	<brief_title>Antibiotic Dosing in Pediatric Intensive Care</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>patients admitted to the pediatric intensive care unit patient age/weight : 1,8 kg15 years patient receiving antibiotic treatment (piperacillintazobactam, amoxicillinclavulanate, vancomycin) via intermittent infusion regimen or continuous infusion according to institutional treatment guidelines intraarterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred) no catheter in place for blood sampling absence of parental/patient consent known hypersensitivity to betalactam antibiotics or glycopeptides extracorporeal circuit (haemodialysis, ECMO, peritoneal dialysis )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>